{"component": "definition", "props": {"groups": [{"size": 5, "samples": [{"hash": "1EHkMDXLbHI", "uri": "/contracts/1EHkMDXLbHI#future-product", "label": "Master Program Services and Product Co Promotion Agreement (Orasure Technologies Inc)", "score": 25.9253935661, "published": true}, {"hash": "hj8VBlbYMAn", "uri": "/contracts/hj8VBlbYMAn#future-product", "label": "Master Program Services and Product Co Promotion Agreement (Orasure Technologies Inc)", "score": 25.5941136208, "published": true}, {"hash": "5ZtEMEgxx0F", "uri": "http://services.corporate-ir.net/SEC/Document.Service?id=P3VybD1hSFIwY0RvdkwyRndhUzUwWlc1cmQybDZZWEprTG1OdmJTOWtiM2R1Ykc5aFpDNXdhSEEvWVdOMGFXOXVQVkJFUmlacGNHRm5aVDA1T1RNNE56azBKbk4xWW5OcFpEMDFOdz09JnR5cGU9MiZmbj1PcmFTdXJlVGVjaG5vbG9naWVzSW5jLnBkZg==", "label": "services.corporate-ir.net", "score": 10.1704312115, "published": false}], "snippet_links": [{"key": "the-product", "type": "clause", "offset": [30, 41]}, {"key": "at-any-time", "type": "clause", "offset": [103, 114]}, {"key": "during-the-term", "type": "clause", "offset": [115, 130]}], "snippet": "means any product, other than the Product, and all improvements to such product, that OraSure Controls at any time during the Term, that is used for the point-of-care detection of HCV antibodies in humans.", "hash": "f79396e64003563714af749d8ebbaccf", "id": 1}, {"size": 5, "samples": [{"hash": "dk3l9DG6crv", "uri": "/contracts/dk3l9DG6crv#future-product", "label": "Intellectual Property Agreement", "score": 29.340862423, "published": true}, {"hash": "2jM72GR699v", "uri": "/contracts/2jM72GR699v#future-product", "label": "Intellectual Property Agreement (CONDUENT Inc)", "score": 28.0061601643, "published": true}, {"hash": "7JlQREnTkpz", "uri": "/contracts/7JlQREnTkpz#future-product", "label": "Intellectual Property Agreement (CONDUENT Inc)", "score": 27.7351129363, "published": true}], "snippet_links": [{"key": "the-context", "type": "clause", "offset": [69, 80]}], "snippet": "means either a Xerox Future Product or a Conduent Future Product, as the context requires.", "hash": "6e28d3545096fc9f96130ea21b9f77ab", "id": 2}, {"size": 4, "samples": [{"hash": "gkXI6oNSB8y", "uri": "/contracts/gkXI6oNSB8y#future-product", "label": "License Agreement (King Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "g2EQkrtCbjF", "uri": "/contracts/g2EQkrtCbjF#future-product", "label": "License Agreement (Acura Pharmaceuticals, Inc)", "score": 21.0, "published": true}, {"hash": "eI0W3K32qVk", "uri": "https://investors.acurapharm.com/static-files/5bf239d8-385d-42fd-bdf7-74a0ce35f776", "label": "investors.acurapharm.com", "score": 9.9650924025, "published": false}], "snippet_links": [{"key": "pharmaceutical-products", "type": "definition", "offset": [30, 53]}, {"key": "human-use", "type": "definition", "offset": [64, 73]}, {"key": "commercialization-in-the-field-in-the-territory", "type": "clause", "offset": [150, 197]}, {"key": "product-a", "type": "definition", "offset": [210, 219]}, {"key": "product-b", "type": "definition", "offset": [224, 233]}, {"key": "each-case", "type": "definition", "offset": [239, 248]}, {"key": "line-extension", "type": "clause", "offset": [272, 286]}], "snippet": "means all orally administered pharmaceutical products [***] for human use, containing [***] in any strength, plus the Aversion\u00ae Composition [***] for Commercialization in the Field in the Territory (other than Product A and Product B), in each case other than any Product Line Extension.", "hash": "9595d9013a2c9d4d5aede79dc82c2abf", "id": 3}, {"size": 4, "samples": [{"hash": "iXFlrYpX8ED", "uri": "/contracts/iXFlrYpX8ED#future-product", "label": "Collaboration Agreement (Biotech Spinco, Inc.)", "score": 21.0, "published": true}, {"hash": "aCHiyqOrIMW", "uri": "/contracts/aCHiyqOrIMW#future-product", "label": "Collaboration Agreement (Facet Biotech Corp)", "score": 21.0, "published": true}, {"hash": "8eDFan9vtXQ", "uri": "/contracts/8eDFan9vtXQ#future-product", "label": "Collaboration Agreement (Protein Design Labs Inc/De)", "score": 21.0, "published": true}], "snippet_links": [], "snippet": "means [****].", "hash": "1e83f8111f883b0fd2a42bcdc6f1004f", "id": 4}, {"size": 3, "samples": [{"hash": "633AWCjZdm7", "uri": "/contracts/633AWCjZdm7#future-product", "label": "Manufacturing Agreement", "score": 31.340862423, "published": true}, {"hash": "dYVRdD84w6", "uri": "/contracts/dYVRdD84w6#future-product", "label": "Manufacturing Agreement (Sonos Inc)", "score": 29.5092402464, "published": true}, {"hash": "flDP7lnmVcI", "uri": "/contracts/flDP7lnmVcI#future-product", "label": "Manufacturing Agreement (Sonos Inc)", "score": 29.1067761807, "published": true}], "snippet_links": [{"key": "in-development", "type": "definition", "offset": [18, 32]}, {"key": "terms-of-this-agreement", "type": "clause", "offset": [78, 101]}, {"key": "statement-of-work", "type": "definition", "offset": [182, 199]}, {"key": "signed-by-both-parties", "type": "clause", "offset": [209, 231]}, {"key": "with-respect-to", "type": "clause", "offset": [232, 247]}, {"key": "mass-production", "type": "definition", "offset": [279, 294]}], "snippet": "means any product in development by Sonos that may become a Product under the terms of this Agreement. A Future Product is not considered a Product until (i) NPI is complete, (ii) a Statement of Work has been signed by both parties with respect to such Future Product, and (iii) Mass Production commences on such Future Product.", "hash": "bf5bccdb0024e58b96892f9866e210f8", "id": 5}, {"size": 2, "samples": [{"hash": "izlAMib1u24", "uri": "/contracts/izlAMib1u24#future-product", "label": "Co Exclusive Manufacturing and Supply Agreement (Angiotech Pharmaceuticals Inc)", "score": 23.8665297741, "published": true}, {"hash": "aXHQd3pqymV", "uri": "/contracts/aXHQd3pqymV#future-product", "label": "Co Exclusive Manufacturing and Supply Agreement (Angiotech Pharmaceuticals Inc)", "score": 23.6173853525, "published": true}], "snippet_links": [{"key": "all-products", "type": "clause", "offset": [14, 26]}, {"key": "initial-products", "type": "clause", "offset": [43, 59]}, {"key": "by-manufacturer", "type": "clause", "offset": [166, 181]}, {"key": "subject-to", "type": "definition", "offset": [186, 196]}, {"key": "product-development-agreement", "type": "definition", "offset": [206, 235]}, {"key": "the-parties", "type": "clause", "offset": [256, 267]}, {"key": "agree-to", "type": "clause", "offset": [287, 295]}, {"key": "in-writing", "type": "definition", "offset": [296, 306]}, {"key": "the-future", "type": "clause", "offset": [310, 320]}, {"key": "this-agreement", "type": "clause", "offset": [342, 356]}], "snippet": "means any and all Products (other than the Initial Products), including any Improvements thereto, and any Improvements to the Initial Products, that are Manufactured by Manufacturer and subject to a Future Product Development Agreement, if needed, or that the Parties otherwise mutually agree to in writing in the future shall become part of this Agreement.", "hash": "d5fcbf37ccbc754593442a0d0cb5f83c", "id": 6}, {"size": 2, "samples": [{"hash": "j79HoDd4ZXg", "uri": "/contracts/j79HoDd4ZXg#future-product", "label": "Patent Purchase Agreement", "score": 30.340862423, "published": true}], "snippet_links": [{"key": "for-seller", "type": "definition", "offset": [97, 107]}, {"key": "based-on", "type": "clause", "offset": [126, 134]}, {"key": "owned-by", "type": "definition", "offset": [148, 156]}, {"key": "created-by", "type": "definition", "offset": [161, 171]}, {"key": "jointly-owned", "type": "definition", "offset": [211, 224]}, {"key": "by-seller", "type": "clause", "offset": [237, 246]}, {"key": "a-third-party", "type": "clause", "offset": [270, 283]}, {"key": "valid-license", "type": "clause", "offset": [522, 535]}, {"key": "grant-of-rights", "type": "definition", "offset": [545, 560]}, {"key": "exercise-of-the", "type": "clause", "offset": [590, 605]}, {"key": "retained-rights", "type": "clause", "offset": [606, 621]}, {"key": "directly-or-indirectly", "type": "clause", "offset": [633, 655]}, {"key": "the-patents", "type": "clause", "offset": [672, 683]}, {"key": "to-seller", "type": "definition", "offset": [706, 715]}, {"key": "each-of-seller", "type": "clause", "offset": [722, 736]}, {"key": "application-specific", "type": "clause", "offset": [861, 881]}, {"key": "circuit-board", "type": "definition", "offset": [904, 917]}, {"key": "third-parties", "type": "definition", "offset": [999, 1012]}, {"key": "product-portfolio", "type": "definition", "offset": [1383, 1400]}, {"key": "the-decision", "type": "clause", "offset": [1433, 1445]}, {"key": "legitimate-business-purpose", "type": "definition", "offset": [1584, 1611]}, {"key": "to-assist", "type": "clause", "offset": [1621, 1630]}, {"key": "engaging-in", "type": "definition", "offset": [1650, 1661]}, {"key": "in-section-6", "type": "clause", "offset": [1708, 1720]}, {"key": "at-any-time", "type": "clause", "offset": [1742, 1753]}, {"key": "the-definition-of", "type": "definition", "offset": [1856, 1873]}, {"key": "specific-component", "type": "definition", "offset": [1953, 1971]}, {"key": "for-the-purpose-of", "type": "definition", "offset": [2025, 2043]}, {"key": "with-respect-to", "type": "clause", "offset": [2100, 2115]}, {"key": "expiration-of", "type": "clause", "offset": [2162, 2175]}, {"key": "after-seller", "type": "definition", "offset": [2203, 2215]}, {"key": "upon-request", "type": "clause", "offset": [2284, 2296]}, {"key": "by-purchaser", "type": "clause", "offset": [2297, 2309]}, {"key": "seller-shall", "type": "clause", "offset": [2311, 2323]}, {"key": "to-purchaser", "type": "definition", "offset": [2341, 2353]}, {"key": "description-of", "type": "definition", "offset": [2356, 2370]}, {"key": "items-included", "type": "clause", "offset": [2384, 2398]}, {"key": "relevant-information", "type": "definition", "offset": [2495, 2515]}, {"key": "notwithstanding-the-foregoing", "type": "clause", "offset": [2617, 2646]}, {"key": "the-term", "type": "definition", "offset": [2648, 2656]}, {"key": "existing-product", "type": "definition", "offset": [2692, 2708]}, {"key": "instrument-of-assignment", "type": "definition", "offset": [2711, 2735]}, {"key": "confidential-treatment-requested", "type": "definition", "offset": [2804, 2836]}, {"key": "confidential-and-proprietary", "type": "clause", "offset": [2837, 2865]}, {"key": "purchaser-and-seller", "type": "clause", "offset": [2869, 2889]}], "snippet": "means: (i) any Component that meets all of the following requirements: (x) it is developed by or for Seller or its Affiliates based on a design (A) owned by and created by or for Seller or its Affiliates or (B) jointly owned and created by Seller or its Affiliates with a third party (other than [...***...]) (y) it does not incorporate or contain, in whole or in part, any Component which is primarily or entirely developed by or for, designed by or for, or otherwise obtained from [...***...] and which would (without a valid license or other grant of rights from Purchaser or the proper exercise of the Retained Rights by Seller) directly or indirectly infringe any of the Patents; and (z) it does not, to Seller\u2019s and each of Seller\u2019s Affiliates\u2019 knowledge, incorporate or contain, in whole or in part, any Supplier Items; or (ii) any finished and complete application specific integrated circuit or circuit board that meets all of the following requirements: (w) it is developed by one or more third parties (other than [...***...]) based exclusively on a design of such one or more third parties (other than [...***...]), (x) it is marketed, resold and distributed on a stand-alone basis by Seller or its Affiliates to a Customer under a brand of Seller or its Affiliates; (y) it does not incorporate or contain, in whole or in part, any Supplier Items; and (z) it complements product portfolio of Seller or its Affiliates and the decision of Seller or its Affiliates to market, resell, and distribute such application specific integrated circuit or circuit board is based on a legitimate business purpose, and not to assist any third party in engaging in any patent laundering activities as described in Section 6 of Schedule 2.5. If, at any time, Seller\u2019s or any of Seller\u2019s Affiliates becomes aware that a Component described in Subsection (i) of the definition of \u201cFuture Product\u201d either incorporates or contains any Supplier Items, then such specific Component shall not be deemed to be a \u201cFuture Product,\u201d solely for the purpose of Subsection (i)(z) of the definition of \u201cFuture Product\u201d with respect to such specific Supplier Items, until after the expiration of a twenty (20)-month period after Seller or any of Seller\u2019s Affiliates first becomes aware of any such fact. Upon request by Purchaser, Seller shall provide promptly to Purchaser a description of all Supplier Items included in any Future Product which Seller or any of its Affiliates becomes aware of, together with all relevant information as to which individuals became aware of, and when they became aware of, each of such Supplier Items. Notwithstanding the foregoing, the term \u201cFuture Product\u201d shall exclude any Existing Product. \u201cInstrument of Assignment\u201d means a document in the form attached hereto as Schedule 1.1(A). * Confidential Treatment Requested Confidential and Proprietary to Purchaser and Seller", "hash": "08a7f4ee00f61643802493e9bd5d581c", "id": 7}, {"size": 2, "samples": [{"hash": "5Ei5UmdiNQG", "uri": "/contracts/5Ei5UmdiNQG#future-product", "label": "Master Inkjet Sale Agreement (Lexmark International Inc /Ky/)", "score": 24.3511293634, "published": true}], "snippet_links": [{"key": "ip-agreement", "type": "clause", "offset": [36, 48]}], "snippet": "has the meaning as set forth in the IP Agreement.", "hash": "b592ff30951ba2e25f1308fac3d5c992", "id": 8}, {"size": 1, "samples": [{"hash": "6s1LgsA1lfg", "uri": "/contracts/6s1LgsA1lfg#future-product", "label": "Distribution Agreement (Bionik Laboratories Corp.)", "score": 28.4907597536, "published": true}], "snippet_links": [{"key": "medical-device-products", "type": "clause", "offset": [17, 40]}, {"key": "current-products", "type": "definition", "offset": [56, 72]}, {"key": "at-any-time", "type": "clause", "offset": [89, 100]}, {"key": "during-the-term-of-this-agreement", "type": "clause", "offset": [101, 134]}, {"key": "in-the-territory", "type": "clause", "offset": [153, 169]}], "snippet": "means any BIONIK medical device products other than the Current Products that BIONIK may at any time during the Term of this Agreement propose to market in the Territory.", "hash": "9c434f8658538b66826394d0adac689e", "id": 9}, {"size": 1, "samples": [{"hash": "jgMvrI06CHW", "uri": "/contracts/jgMvrI06CHW#future-product", "label": "Stock Purchase Agreement (Chiron Corp)", "score": 18.0, "published": true}], "snippet_links": [{"key": "in-development", "type": "definition", "offset": [52, 66]}], "snippet": "means any product other than a Product or a Product In Development.", "hash": "001d769cada21e1811d28663da3f100d", "id": 10}], "next_curs": "ClsSVWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjcLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIXZnV0dXJlLXByb2R1Y3QjMDAwMDAwMGEMogECZW4YACAA", "definition": {"size": 36, "title": "Future Product", "snippet": "means any product, other than the Product, and all improvements to such product, that OraSure Controls at any time during the Term, that is used for the point-of-care detection of HCV antibodies in humans.", "id": "future-product", "examples": ["The foregoing request/approval process shall also apply during NPI for any Transfer Product or <strong>Future Product</strong>.", "AMD shall have no purchase commitment with respect to any Other <strong>Future Products</strong>; provided, however, that in the event AMD introduces a tape-out of any Other <strong>Future Products</strong>, FoundryCo shall have a right of first refusal in accordance with the process set forth in Exhibit B to manufacture such Other <strong>Future Product</strong> (including the first tape-out of such Other <strong>Future Product</strong>), subject to Qualification of such Other <strong>Future Product</strong> at such Process Node.", "AMD agrees to invite FoundryCo to participate in the RFQ process for any and all GPU Products and Other <strong>Future Products</strong> that are being developed within AMD (including the first tape-out of such GPU Product or Other <strong>Future Product</strong>) that could potentially be manufactured at FoundryCo. AMD agrees to share present and <strong>future product</strong> requirements with FoundryCo so that FoundryCo can adequately respond to any RFQ requests coming from AMD.", "If, after a proposal is made under Section 3.10(a), the JSC does not approve the addition of a new Product as a <strong>Future Product</strong> or an additional Indication for an existing Collaboration Product or a new formulation of an existing Collaboration Product, but determines that such Product or additional Indication or formulation should be subject to further evaluation then such Product or additional Indication or formulation shall be subject to this Section 3.10(b)(ii).", "For purposes of clarity, the Parties agree that if the JSC is unable to agree on the specific goals for the foregoing work plan or is unable to agree that if the work plan meets its goals the Parties would jointly Develop the new product as a <strong>Future Product</strong> or an additional clinical indication for an existing Collaboration Product or a new formulation of an existing Collaboration Product, such disagreement shall not be subject to dispute resolution hereunder and shall be considered final.", "I-Link shall make available to Big Planet such <strong>Future Product</strong> or Service for testing by Big Planet at such time as such <strong>Future Product</strong> or Service is functional and marketable.", "EXHIBIT B: [****] PROCESS Subject to Section 2.1(c) of this Agreement, AMD will continually provide FoundryCo with the opportunity to respond to GPU Product business opportunities and Other <strong>Future Product</strong> business opportunities.", "If Big Planet indicates that it is not interested in marketing such <strong>Future Product</strong> or Service, then I-Link may contract with other parties to market and distribute such <strong>Future Product</strong> or Service within the Network Marketing Channel provided such <strong>Future Product</strong> or Service is a Stand-Alone Product.", "With respect to any given country, territory or jurisdiction, so long as Big Planet shall retain its exclusive rights within such country, territory or jurisdiction as provided in Sections 4.3 and 4.4 above, and Section 4.17 below, I-Link hereby grants Big Planet a right of first option to exclusively market in the Network Marketing Channel within any such country, territory or jurisdiction any <strong>Future Product</strong> or Service that it releases to market.", "The Commercialization of each <strong>Future Product</strong> will be carried out in accordance with a Commercialization Plan."], "related": [["new-product", "New Product", "New Product"], ["commercial-product", "Commercial Product", "Commercial Product"], ["hemp-product", "Hemp product", "Hemp product"], ["new-products", "New Products", "New Products"], ["licensed-product", "Licensed Product", "Licensed Product"]], "related_snippets": [], "updated": "2025-07-06T21:56:50+00:00"}, "json": true, "cursor": ""}}